Integrated Diagnostics Holdings IDHC.L · GBp

Its shares trade on LSE under the ticker IDHC.L. It has been listed since 6 May 2015. In the fiscal year to 31 December 2025, it reported revenue of EGP 7.86bn and net income of EGP 1.26bn. At that date it held total assets of EGP 8.60bn and shareholders' equity of EGP 3.38bn.

Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in three geographic areas: Egypt, Sudan and Jordan. The firm provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The firm offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The firm's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The firm also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.

Figures and description from our data supplier, not checked against the company's own report.

• Lord Anthony St John Of BlestoNon-Executive Independent ChairmanEGP 4.6m
• Prof. Dr. Hend El SherbiniGroup Chief Executive Officer, Executive Director, since 2014EGP 25.1m
• Mr. Sherif Mohammed El ZeinyGroup Chief Financial Officer, Vice President, Executive Director, since 2024EGP 16.4m
• Mr. Richard PhillipsNon-Executive Director
• Mr. Hussein Hasan ChoucriNon-Executive Independent DirectorEGP 3.0m
• Mr. Dan OlssonNon-Executive Independent DirectorEGP 3.2m
• Ms. Yvonne StillhartNon-Executive Independent DirectorEGP 3.0m
• Mr. Tarek YehiaInvestor Relations Director, since 2024

Overall

38

Environment

31

Social

50

Governance

34

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.